milvexian
janssen,bms
['factor xi', 'milvexian', 'bms', 'janssen', 'bristol']
meanwhile, the factor xia inhibitor from bristol myers squibb + johnson &amp; johnson's janssen, also missed the composite endpoint in a stroke study w/&gt;2,300 patients the drugmakers will take milvexian into a phase iii later this year, according to bms 
reporting on the science, people, $ & biotechs behind new meds @Endpts | Tips? klahucik@endpointsnews.com | asking Q's, jogging 26.2 | ?? ?? ?? | he/him ??????